BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31939629)

  • 1. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
    Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
    Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.
    Dong J; Xu M
    Oncol Rep; 2019 Jun; 41(6):3233-3243. PubMed ID: 31002358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a SVM classifier to predict recurrence of ovarian cancer.
    Zhou J; Li L; Wang L; Li X; Xing H; Cheng L
    Mol Med Rep; 2018 Oct; 18(4):3589-3598. PubMed ID: 30106117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A six‑gene support vector machine classifier contributes to the diagnosis of pediatric septic shock.
    Long G; Yang C
    Mol Med Rep; 2020 Mar; 21(3):1561-1571. PubMed ID: 32016447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.
    Yang J; Bo L; Han T; Ding D; Nie M; Yin K
    Mol Med Rep; 2018 May; 17(5):6345-6356. PubMed ID: 29532879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.
    Yang L; Sun L; Wang W; Xu H; Li Y; Zhao JY; Liu DZ; Wang F; Zhang LY
    Mol Med Rep; 2018 Feb; 17(2):3005-3013. PubMed ID: 29257283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
    Tuo Y; An N; Zhang M
    Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
    Tang Z; Wei G; Zhang L; Xu Z
    Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of recurrent risk-related genes and establishment of support vector machine prediction model for gastric cancer.
    Liu B; Tan J; Wang X; Liu X
    Neoplasma; 2018 Mar; 65(3):360-366. PubMed ID: 29788739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 13. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
    Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
    J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit.
    Jiang Y; Xie J; Han Z; Liu W; Xi S; Huang L; Huang W; Lin T; Zhao L; Hu Y; Yu J; Zhang Q; Li T; Cai S; Li G
    Clin Cancer Res; 2018 Nov; 24(22):5574-5584. PubMed ID: 30042208
    [No Abstract]   [Full Text] [Related]  

  • 16. A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
    Liu Y; Zhu D; Xing H; Hou Y; Sun Y
    Oncol Rep; 2019 Mar; 41(3):1521-1530. PubMed ID: 30747226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
    Xu G; Zhang M; Zhu H; Xu J
    Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk gene identification and support vector machine learning to construct an early diagnosis model of myocardial infarction.
    Fang HZ; Hu DL; Li Q; Tu S
    Mol Med Rep; 2020 Sep; 22(3):1775-1782. PubMed ID: 32705275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
    Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B
    Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.